Observational Study Describing the Immune Profile Induced By Pertussis

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04056728` - A Phase IV Study to Assess the Safety of EupentaTM Inj	Phase 4
Completed	`NCT02453048` - Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine	Phase 1
Completed	`NCT01917357` - A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject	Phase 3
Completed	`NCT02526394` - Pertussis and Meningitis C Concomitant Vaccination in Adolescents	Phase 4
Completed	`NCT01689324` - Study of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (ADACEL®) as a Booster in Adolescents	Phase 1/Phase 2
Completed	`NCT01214889` - Study of PENTAXIM™ Vaccine Versus TETRAXIM™ Vaccine Given With ACTHIB™ Vaccine in South Korean Infants.	Phase 3
Completed	`NCT00804284` - Database Surveillance Safety Study of PENTACEL® Vaccine	N/A
Completed	`NCT00514709` - Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB PRP~T Combined Vaccine in Filipino Infants	Phase 3
Completed	`NCT00534833` - Immunogenicity Study of Antibody Persistence and Booster Effect of DTaP-HB-PRP~T Combined Vaccine or Tritanrix-HepB/Hib™	Phase 3
Completed	`NCT00524732` - Assessment of the Reactogenicity of ADACEL® (TdcP Vaccine) in Children and Adolescents 7 to 19 Years of Age	N/A
Completed	`NCT00772369` - Retrospective Survey of Safety of Fourth Dose Pentacel® in Children	Phase 4
Completed	`NCT01457495` - Immunogenicity and Safety of DTPa-HBV-IPV/Hib Compared to DTPa-IPV/Hib and HBV Administered Concomitantly	Phase 2
Completed	`NCT01267058` - Booster Study of Combined Diphtheria-tetanus-acellular Pertussis Vaccine in Healthy Adults	Phase 3
Completed	`NCT00004800` - Phase III Randomized, Double-Blind, Placebo-Controlled Study of Acellular and Whole-Cell Pertussis Vaccines	Phase 3
Completed	`NCT02858440` - A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia	Phase 3
Recruiting	`NCT04023929` - Sources of COmplement in Meningococcal and Pertussis Serum Bactericidal Antibody Assays
Completed	`NCT02946190` - The PertADO Geneva Trial	Phase 2
Completed	`NCT03541499` - Safety and Immunogenicity of Intranasal BPZE1 Vaccination in Healthy Adults	Phase 2
Completed	`NCT02587520` - Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects	Phase 1/Phase 2
Completed	`NCT04589312` - Maternal Pertussis Wholecell Responses	Phase 2

NCT number	NCT03147898
Study type	Observational
Source	Sanofi
Contact
Status	Completed
Phase
Start date	April 12, 2017
Completion date	July 9, 2018

Observational Study Describing the Immune Profile Induced By Pertussis Vaccines

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms